Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
AARTIDRUGSNSE
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 8% | 4% | -2% | 7% |
| 11% | -7% | 5% | 16% |
| 11% | -7% | -7% | -15% |
| 19% | 15% | 13% | 13% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
AARTIDRUGS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 437.25 | ₹3982 Cr | 20.83 | 5.5 | 28.69 | ₹195 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹91 Cr | ₹91 Cr | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹23 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹21 L | ₹0 | ₹0 | ₹0 |
| ₹1458 Cr | ₹1278 Cr | ₹1190 Cr | ₹1100 Cr | ₹944 Cr | ₹820 Cr | ₹629 Cr | ₹520 Cr | ₹432 Cr | ₹376 Cr | ₹333 Cr | ₹284 Cr | ₹151 Cr | ₹134 Cr | ₹112 Cr | ₹100 Cr | ₹88 Cr | ₹76 Cr |
| ₹1458 Cr | ₹1278 Cr | ₹1190 Cr | ₹1100 Cr | ₹944 Cr | ₹820 Cr | ₹629 Cr | ₹520 Cr | ₹432 Cr | ₹376 Cr | ₹333 Cr | ₹284 Cr | ₹151 Cr | ₹134 Cr | ₹112 Cr | ₹100 Cr | ₹88 Cr | ₹76 Cr |
| ₹1549 Cr | ₹1369 Cr | ₹1282 Cr | ₹1192 Cr | ₹1036 Cr | ₹913 Cr | ₹652 Cr | ₹543 Cr | ₹455 Cr | ₹400 Cr | ₹357 Cr | ₹308 Cr | ₹163 Cr | ₹146 Cr | ₹123 Cr | ₹112 Cr | ₹100 Cr | ₹88 Cr |
| ₹36 L | ₹34 L | ₹41 L | ₹23 L | -₹6 L | -₹2 L | -₹21,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹5 Cr | ₹9 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr |
| ₹253 Cr | ₹280 Cr | ₹272 Cr | ₹196 Cr | ₹130 Cr | ₹139 Cr | ₹172 Cr | ₹200 Cr | ₹191 Cr | ₹187 Cr | ₹177 Cr | ₹153 Cr | ₹205 Cr | ₹139 Cr | ₹161 Cr | ₹128 Cr | ₹123 Cr | ₹105 Cr |
| ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹11 Cr | ₹63 Cr | ₹50 Cr | ₹31 Cr | ₹90 Cr | ₹76 Cr | ₹85 Cr |
| ₹81 Cr | ₹78 Cr | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr | ₹81 Cr | ₹90 Cr | ₹81 Cr | ₹72 Cr | ₹40 Cr | ₹35 Cr | ₹23 Cr | ₹21 Cr | ₹18 Cr | ₹16 Cr | ₹13 Cr | ₹11 Cr |
| ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹57 L | ₹2 Cr | ₹5 Cr | ₹8 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹9 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹11 Cr | ₹7 Cr | ₹8 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹9 Cr | ₹22 Cr | ₹25 Cr | ₹12 Cr | ₹17 Cr | ₹8 Cr | ₹1 Cr | ₹29 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹344 Cr | ₹368 Cr | ₹355 Cr | ₹279 Cr | ₹232 Cr | ₹257 Cr | ₹301 Cr | ₹321 Cr | ₹312 Cr | ₹297 Cr | ₹244 Cr | ₹211 Cr | ₹290 Cr | ₹210 Cr | ₹211 Cr | ₹233 Cr | ₹213 Cr | ₹201 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹478 Cr | ₹416 Cr | ₹425 Cr | ₹480 Cr | ₹469 Cr | ₹330 Cr | ₹330 Cr | ₹243 Cr | ₹259 Cr | ₹197 Cr | ₹185 Cr | ₹167 Cr | ₹65 Cr | ₹50 Cr | ₹55 Cr | ₹54 Cr | ₹39 Cr | ₹51 Cr |
| ₹181 Cr | ₹145 Cr | ₹151 Cr | ₹100 Cr | ₹111 Cr | ₹105 Cr | ₹133 Cr | ₹83 Cr | ₹56 Cr | ₹51 Cr | ₹44 Cr | ₹42 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹80 L | ₹86 L | ₹73 L |
| ₹248 Cr | ₹272 Cr | ₹215 Cr | ₹361 Cr | ₹356 Cr | ₹157 Cr | ₹158 Cr | ₹263 Cr | ₹306 Cr | ₹245 Cr | ₹258 Cr | ₹252 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹15 Cr | ₹4 Cr | ₹4 Cr | ₹9 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹89 L | ₹2 Cr | ₹14 Cr | ₹22 Cr | ₹3 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹0 | ₹14 Cr |
| ₹922 Cr | ₹837 Cr | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr | ₹623 Cr | ₹591 Cr | ₹622 Cr | ₹494 Cr | ₹501 Cr | ₹483 Cr | ₹70 Cr | ₹58 Cr | ₹60 Cr | ₹57 Cr | ₹40 Cr | ₹65 Cr |
| ₹2815 Cr | ₹2575 Cr | ₹2432 Cr | ₹2421 Cr | ₹2208 Cr | ₹1766 Cr | ₹1577 Cr | ₹1455 Cr | ₹1389 Cr | ₹1191 Cr | ₹1102 Cr | ₹1002 Cr | ₹523 Cr | ₹419 Cr | ₹403 Cr | ₹417 Cr | ₹366 Cr | ₹367 Cr |
| ₹331 Cr | ₹267 Cr | ₹249 Cr | ₹194 Cr | ₹185 Cr | ₹151 Cr | ₹88 Cr | ₹74 Cr | ₹53 Cr | ₹61 Cr | ₹67 Cr | ₹74 Cr | ₹30 Cr | ₹17 Cr | ₹15 Cr | ₹13 Cr | ₹23 Cr | ₹11 Cr |
| ₹575 Cr | ₹612 Cr | ₹562 Cr | ₹607 Cr | ₹538 Cr | ₹344 Cr | ₹379 Cr | ₹507 Cr | ₹546 Cr | ₹479 Cr | ₹483 Cr | ₹448 Cr | ₹267 Cr | ₹189 Cr | ₹192 Cr | ₹217 Cr | ₹199 Cr | ₹190 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1781 Cr | ₹1494 Cr | ₹1388 Cr | ₹1202 Cr | ₹1169 Cr | ₹1101 Cr | ₹1031 Cr | ₹970 Cr | ₹909 Cr | ₹848 Cr | ₹725 Cr | ₹685 Cr | ₹393 Cr | ₹332 Cr | ₹310 Cr | ₹278 Cr | ₹255 Cr | ₹241 Cr |
| ₹695 Cr | ₹628 Cr | ₹577 Cr | ₹526 Cr | ₹479 Cr | ₹436 Cr | ₹387 Cr | ₹345 Cr | ₹307 Cr | ₹267 Cr | ₹232 Cr | ₹237 Cr | ₹145 Cr | ₹124 Cr | ₹105 Cr | ₹88 Cr | ₹72 Cr | ₹58 Cr |
| ₹1086 Cr | ₹866 Cr | ₹811 Cr | ₹676 Cr | ₹690 Cr | ₹665 Cr | ₹644 Cr | ₹625 Cr | ₹602 Cr | ₹581 Cr | ₹493 Cr | ₹448 Cr | ₹248 Cr | ₹208 Cr | ₹205 Cr | ₹190 Cr | ₹183 Cr | ₹183 Cr |
| ₹121 Cr | ₹274 Cr | ₹225 Cr | ₹187 Cr | ₹77 Cr | ₹19 Cr | ₹12 Cr | ₹33 Cr | ₹28 Cr | ₹14 Cr | ₹34 Cr | ₹16 Cr | ₹10 Cr | ₹3 Cr | ₹64 L | ₹15 Cr | ₹14 Cr | ₹1 Cr |
| ₹27 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹13 Cr | ₹1 Cr | ₹32 L |
| ₹27 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹13 Cr | ₹1 Cr | ₹32 L |
| ₹20 Cr | ₹18 Cr | ₹20 Cr | ₹24 Cr | ₹28 Cr | ₹7 Cr | ₹3 Cr | ₹1 Cr | ₹11 Cr | ₹12 Cr | ₹5 Cr | ₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹1347 Cr | ₹1236 Cr | ₹1112 Cr | ₹930 Cr | ₹815 Cr | ₹709 Cr | ₹673 Cr | ₹671 Cr | ₹653 Cr | ₹620 Cr | ₹537 Cr | ₹476 Cr | ₹263 Cr | ₹213 Cr | ₹207 Cr | ₹218 Cr | ₹198 Cr | ₹185 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹491 Cr | ₹473 Cr | ₹486 Cr | ₹516 Cr | ₹526 Cr | ₹415 Cr | ₹325 Cr | ₹247 Cr | ₹278 Cr | ₹210 Cr | ₹178 Cr | ₹164 Cr | ₹92 Cr | ₹64 Cr | ₹61 Cr | ₹66 Cr | ₹62 Cr | ₹68 Cr |
| ₹830 Cr | ₹751 Cr | ₹705 Cr | ₹865 Cr | ₹750 Cr | ₹555 Cr | ₹489 Cr | ₹459 Cr | ₹375 Cr | ₹297 Cr | ₹332 Cr | ₹314 Cr | ₹121 Cr | ₹116 Cr | ₹113 Cr | ₹103 Cr | ₹79 Cr | ₹75 Cr |
| ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹22 Cr | ₹10 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹9 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹7 Cr |
| ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹70 L | ₹2 Cr | ₹2 Cr | ₹7 Cr | ₹10 Cr | ₹0 | ₹0 | ₹0 | ₹90 L | ₹100 L | ₹80 L | ₹78 L | ₹83 L | ₹82 L |
| ₹134 Cr | ₹103 Cr | ₹118 Cr | ₹99 Cr | ₹95 Cr | ₹74 Cr | ₹75 Cr | ₹67 Cr | ₹69 Cr | ₹61 Cr | ₹50 Cr | ₹43 Cr | ₹41 Cr | ₹16 Cr | ₹18 Cr | ₹24 Cr | ₹20 Cr | ₹30 Cr |
| ₹1468 Cr | ₹1338 Cr | ₹1321 Cr | ₹1492 Cr | ₹1393 Cr | ₹1057 Cr | ₹899 Cr | ₹784 Cr | ₹737 Cr | ₹571 Cr | ₹565 Cr | ₹526 Cr | ₹260 Cr | ₹206 Cr | ₹196 Cr | ₹199 Cr | ₹167 Cr | ₹180 Cr |
| ₹546 Cr | ₹501 Cr | ₹525 Cr | ₹542 Cr | ₹453 Cr | ₹461 Cr | ₹276 Cr | ₹193 Cr | ₹115 Cr | ₹77 Cr | ₹64 Cr | ₹43 Cr | ₹190 Cr | ₹148 Cr | ₹136 Cr | ₹141 Cr | ₹128 Cr | ₹115 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹9,845 | ₹13,125 | ₹16,405 | ₹4 L | ₹1 Cr | ₹2 Cr |
| ₹2815 Cr | ₹2575 Cr | ₹2432 Cr | ₹2421 Cr | ₹2208 Cr | ₹1766 Cr | ₹1577 Cr | ₹1455 Cr | ₹1389 Cr | ₹1191 Cr | ₹1102 Cr | ₹1002 Cr | ₹523 Cr | ₹419 Cr | ₹403 Cr | ₹417 Cr | ₹366 Cr | ₹367 Cr |
| ₹170 | ₹150 | ₹139 | ₹129 | ₹112 | ₹98 | ₹280 | ₹230 | ₹193 | ₹168 | ₹148 | ₹127 | ₹135 | ₹121 | ₹105 | ₹95 | ₹85 | ₹73 |
| ₹170 | ₹150 | ₹139 | ₹129 | ₹112 | ₹98 | ₹70 | ₹58 | ₹48 | ₹42 | ₹37 | ₹32 | ₹17 | ₹15 | ₹13 | ₹12 | ₹11 | ₹9 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹211 Cr | ₹212 Cr | ₹236 Cr | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹185 Cr | ₹131 Cr | ₹125 Cr | ₹116 Cr | ₹95 Cr | ₹100 Cr | ₹33 Cr | ₹47 Cr | ₹26 Cr | ₹20 Cr | ₹19 Cr |
| ₹103 Cr | ₹84 Cr | ₹83 Cr | ₹85 Cr | ₹71 Cr | ₹69 Cr | ₹87 Cr | ₹75 Cr | ₹75 Cr | ₹72 Cr | ₹79 Cr | ₹69 Cr | ₹39 Cr | ₹39 Cr | ₹42 Cr | ₹28 Cr | ₹24 Cr |
| -₹64 Cr | ₹4 Cr | ₹103 Cr | -₹116 Cr | -₹187 Cr | -₹186 Cr | ₹19 Cr | -₹33 Cr | -₹105 Cr | ₹8 Cr | -₹21 Cr | -₹50 Cr | -₹40 Cr | -₹13 Cr | ₹2 Cr | -₹15 Cr | -₹11 Cr |
| ₹249 Cr | ₹300 Cr | ₹421 Cr | ₹193 Cr | ₹154 Cr | ₹252 Cr | ₹292 Cr | ₹173 Cr | ₹94 Cr | ₹196 Cr | ₹153 Cr | ₹120 Cr | ₹32 Cr | ₹73 Cr | ₹70 Cr | ₹32 Cr | ₹32 Cr |
| ₹254 Cr | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr | ₹155 Cr | ₹251 Cr | ₹143 Cr | ₹70 Cr | ₹175 Cr | ₹133 Cr | ₹105 Cr | ₹21 Cr | ₹59 Cr | ₹65 Cr | ₹28 Cr | ₹29 Cr |
| -₹173 Cr | -₹165 Cr | -₹224 Cr | -₹164 Cr | -₹150 Cr | -₹72 Cr | -₹33 Cr | -₹62 Cr | -₹74 Cr | -₹107 Cr | -₹99 Cr | -₹107 Cr | -₹76 Cr | -₹30 Cr | -₹12 Cr | -₹33 Cr | -₹25 Cr |
| -₹77 Cr | -₹82 Cr | -₹136 Cr | ₹17 Cr | ₹92 Cr | -₹81 Cr | -₹215 Cr | -₹80 Cr | ₹4 Cr | -₹68 Cr | -₹33 Cr | ₹1 Cr | ₹53 Cr | -₹24 Cr | -₹54 Cr | ₹4 Cr | -₹6 Cr |
| ₹3 Cr | -₹2 Cr | -₹76 L | -₹14 Cr | ₹13 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹15 L | -₹45 L | ₹1 Cr | -₹95 L | -₹3 Cr | ₹5 Cr | -₹53 L | -₹1 Cr | -₹2 Cr |
| ₹5 Cr | ₹7 Cr | ₹8 Cr | ₹22 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹9 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹7 Cr |
| ₹7 Cr | ₹5 Cr | ₹7 Cr | ₹8 Cr | ₹22 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹9 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr |
Fundamental Ratios
Consolidated
Standalone
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 3 out of 9 oscillators
RSI
58.20Buy
STOCH %K
66.96Neutral
MACD Level(12,26)
4.59Buy
Ultimate Oscillator
43.63Sell
Aroon Oscillator
24.00Sell
BOP
0.06Buy
CCI
156.99Sell
Williams %R
-33.04Neutral
Momentum
11.40Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
431.40Buy
SMA 9
430.45Buy
EMA 21
427.14Buy
SMA 21
426.07Buy
EMA 50
418.06Buy
SMA 50
420.66Buy
EMA 200
403.60Buy
SMA 200
387.63Buy
WMA 20
429.25Buy
Pivot
Pivot
Classic
Resistance 5
497.92
Resistance 4
482.42
Resistance 3
466.92
Resistance 2
451.42
Resistance 1
443.83
Pivot
435.92
Support 1
428.33
Support 2
420.42
Support 3
404.92
Support 4
389.42
Support 5
373.92
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 54.43% | 55.03% | 55.03% | 54.72% | 55.22% | 55.48% |
| 1.52% | 1.57% | 2.15% | 2.68% | 2.26% | 2.25% |
| 0.21% | 0.08% | 0.09% | 0.09% | 0.09% | 0.95% |
| 10.08% | 10.14% | 10.03% | 9.81% | 9.85% | 8.75% |
| 33.76% | 33.18% | 32.70% | 32.70% | 32.58% | 32.57% |
Bulk & block deals
Name
Graviton Research Capital Llp
Graviton Research Capital Llp
Blend Fund 2
Mirik Rajendra Gogri
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Nk Securities Research Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 07 May 2025 | Purchase | 31.58 Cr | ₹393.10 | 8.03 L | Bulk | 0.88033 | NSE |
| 07 May 2025 | Sell | 31.63 Cr | ₹393.62 | 8.04 L | Bulk | 0.88056 | NSE |
| 28 May 2024 | Purchase | 24.81 Cr | ₹484.97 | 5.12 L | Bulk | 0.560503 | NSE |
| 28 May 2024 | Sell | 22.74 Cr | ₹485.50 | 4.68 L | Bulk | 0.513178 | NSE |
| 18 Oct 2023 | Purchase | 26.60 Cr | ₹554.17 | 4.80 L | Bulk | 0.525996 | NSE |
| 18 Oct 2023 | Sell | 26.63 Cr | ₹554.70 | 4.80 L | Bulk | 0.525996 | NSE |
| 25 Jul 2023 | Purchase | 58.59 Cr | ₹627.89 | 9.33 L | Bulk | 1.022307 | NSE |
| 25 Jul 2023 | Sell | 58.63 Cr | ₹628.40 | 9.33 L | Bulk | 1.022307 | NSE |
| 24 Jul 2023 | Purchase | 37.07 Cr | ₹575.88 | 6.44 L | Bulk | 0.705329 | NSE |
| 24 Jul 2023 | Purchase | 32.56 Cr | ₹588.25 | 5.54 L | Bulk | 0.606481 | NSE |
Insider trading & SAST
Client name
Dilesh Roadlines Pvt Ltd & Others
Dsp Trustee Pvt Ltd & Others
Rajendra Vallabhaji Gogri & Others
Seema Harshit Savla & Others
Mirik Rajendra Gogri & Others
Mirik Rajendra Gogri & Others
Safechem Enterprises Private Limited
Arun Moreshwar Patil
Uday Moreshwar Patil
Uday Moreshwar Patil
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jul 2026 | Promoter | Disposal | 1.67 | 54.43 | 0 | — | 22.66 L | 28 May 2024 - 24 Jun 2026 | Market | 4,96,81,228 | SAST | 29(2) | — |
| 16 Apr 2025 | Other | Acquisition | 0.02 | 7.04 | 0 | — | 19.57 K | 21 Mar 2025 | Market | 64,22,463 | SAST | 29(2) | — |
| 03 Jun 2024 | Promoter | Disposal | 2 | 55.7 | 0 | — | 18.38 L | 22 Dec 2023 - 28 May 2024 | Market | 5,12,06,711 | SAST | 29(2) | — |
| 09 Jan 2024 | Promoter | Disposal | 1.86 | 57.7 | 0 | — | 17.08 L | 12 Jun 2023 - 22 Dec 2023 | Market | 5,30,44,829 | SAST | 29(2) | — |
| 06 Jul 2023 | Promoter | Acquisition | 44.07 | — | 0 | — | 4.08 Cr | 09 Jun 2023 | Market | — | SAST | 29(2) | — |
| 27 Jun 2023 | Promoter | Acquisition | 44.07 | — | 0 | — | 4.08 Cr | 09 Jun 2023 | Market | — | SAST | 29(2) | — |
| 02 Jan 2022 | Promoter Group | Disposal | 0.010799 | 1.32 | 52.41 L | ₹524.06 | 10 K | 30 Dec 2021 | Market Sale | 12,22,662 | Insider Trading | — | Equity Shares |
| 08 Mar 2022 | Promoter Group | Acquisition | 0.000658 | 0.08 | 2.80 L | ₹459.35 | 609 | 02 Mar 2022 | Market Purchase | 70,000 | Insider Trading | — | Equity Shares |
| 03 Mar 2022 | Promoter Group | Acquisition | 0.00054 | 0.05 | 2.30 L | ₹459.71 | 500 | 28 Feb 2022 | Market Purchase | 50,922 | Insider Trading | — | Equity Shares |
| 03 Mar 2022 | Promoter Group | Acquisition | 0.00054 | 0.05 | 2.60 L | ₹520.98 | 500 | 20 Dec 2021 | Market Purchase | 50,422 | Insider Trading | — | Equity Shares |
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Aarti Drugs Limited was established in the year 1984 and forms part of Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close
Corporate Actions
Date
Type
Details
Company details
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Aarti Drugs Share Price
437.25+1.00 (+0.23%)
-15.24% past 1 Year
News
Aarti Drugs appoints new chairman and managing director from October 2026
Equity
AARTIDRUGS
Aarti Drugs appoints Adhish P. Patil as Managing Director for five years
Equity
AARTIDRUGS
Aarti Drugs reports strong Q1 EBITDA growth and margin expansion YoY
Equity
AARTIDRUGS
Aarti Drugs reports higher Q1 revenue on year, details not disclosed
Equity
AARTIDRUGS
Aarti Drugs Q1 FY27 consolidated net profit declines marginally year on year
Equity
AARTIDRUGS
Aarti Drugs ordered to shut Gujarat Saykha Amines plant by GPCB directive
Equity
AARTIDRUGS
Aarti Drugs informs about newspaper publication
Equity
AARTIDRUGS
Aarti Drugs Q4 EBITDA declines year-on-year with narrower operating margins reported
Equity
AARTIDRUGS
Aarti Drugs Q4 FY earnings show revenue growth but net profit decline YoY
Equity
AARTIDRUGS
Aarti Drugs reports Profit after tax of 44.96 Crores, in the March 2026 quarter
Equity
AARTIDRUGS
Aarti Drugs informs about newspaper publication
Equity
AARTIDRUGS
Aarti Drugs gets nod to make investment in Pinnacle Life Science
Equity
AARTIDRUGS
Aarti Drugs informs about investment in equity shares of WOS
Equity
AARTIDRUGS
Aarti Drugs rises as its arm incorporates overseas wholly owned subsidiary
Equity
AARTIDRUGS
Aarti Drugs’ arm incorporates overseas wholly owned subsidiary
Equity
AARTIDRUGS
Aarti Drugs - Quaterly Results
Equity
AARTIDRUGS
Aarti Drugs Declares Interim Dividend of Rs 2 Per Share for FY2025-26
Equity
AARTIDRUGS
Aarti Drugs Q3 FY26 EBITDA Declines YoY Amid Margin Compression
Equity
AARTIDRUGS
Aarti Drugs Q3FY25 Earnings: Net Profit Up 1.1% YoY to Rs 37 Crore, Revenue Down 8.1% to Rs 557 Crore.
Equity
AARTIDRUGS
Aarti Drugs reports Profit after tax of 33.84 Crores, in the December 2025 quarter
Equity
AARTIDRUGS

